Owing to the poor prognosis of high-risk neuroblastoma, there are many innovative therapeutic approaches being trialed in different countries. As early-phase clinical trials of new agents involve ...

A gene-expression profile study, combined with analysis by artificial neural networks, has been developed to predict outcome of patients with neuroblastoma. Fifty-six primary neuroblastoma tumour ...